Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$820M |
| 2 |
Palo Alto Networks
PANW
|
+$358M |
| 3 |
Visa
V
|
+$355M |
| 4 |
CELG
Celgene Corp
CELG
|
+$339M |
| 5 |
Citigroup
C
|
+$325M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$722M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
+$356M |
| 3 |
Alibaba
BABA
|
+$345M |
| 4 |
EOG Resources
EOG
|
+$344M |
| 5 |
Canadian Pacific Kansas City
CP
|
+$321M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.49% |
| 2 | Consumer Discretionary | 17.83% |
| 3 | Communication Services | 14.3% |
| 4 | Technology | 13.78% |
| 5 | Financials | 10.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
726
Amgen
AMGN
$204B
| – | – |
-23,445
| Closed | -$3.6M |
|
727
Ameriprise Financial
AMP
$49.1B
| – | – |
-29,348
| Closed | -$3.67M |
|
728
Ashland
ASH
$3.19B
| – | – |
-13,705
| Closed | -$817K |
|
729
Franklin Templeton
BEN
$16.8B
| – | – |
-71,329
| Closed | -$3.5M |
|
730
Bunge Global
BG
$23.5B
| – | – |
-1,550,275
| Closed | -$136M |
|
731
Baidu
BIDU
$30.8B
| – | – |
-1,172
| Closed | -$233K |
|
732
PUT
Biogen
BIIB
$31.7B
| – | – |
-44,800
| Closed | -$18.1M |
|
733
CrossAmerica Partners
CAPL
$854M
| – | – |
-120,445
| Closed | -$3.4M |
|
734
Caterpillar
CAT
$357B
| – | – |
-14,228
| Closed | -$1.21M |
|
735
CALL
Centene
CNC
$33.4B
| – | – |
-500,000
| Closed | -$20.1M |
|
736
Canadian Natural Resources
CNQ
$105B
| – | – |
-116,072
| Closed | -$1.52M |
|
|
ESPR
737
CALL
DELISTED
Esperion Therapeutics
ESPR
| – | – |
-200,000
| Closed | -$16.4M |
|
|
ESPR
738
DELISTED
Esperion Therapeutics
ESPR
| – | – |
-70,720
| Closed | -$5.78M |
|
739
Evolent Health
EVH
$448M
| – | – |
-49,826
| Closed | -$972K |
|
740
Evercore
EVR
$10.4B
| – | – |
-7,416
| Closed | -$400K |
|
741
Edwards Lifesciences
EW
$49.2B
| – | – |
-170,730
| Closed | -$4.05M |
|
742
Corning
GLW
$124B
| – | – |
-173,583
| Closed | -$3.42M |
|
743
General Motors
GM
$75.2B
| – | – |
-1,272,830
| Closed | -$42.4M |
|
744
PUT
Incyte
INCY
$24.3B
| – | – |
-130,000
| Closed | -$13.5M |
|
745
Kohl's
KSS
$1.89B
| – | – |
-25,088
| Closed | -$1.57M |
|
746
L3Harris
LHX
$46.4B
| – | – |
-28,204
| Closed | -$2.17M |
|
747
Lockheed Martin
LMT
$122B
| – | – |
-4,132
| Closed | -$768K |
|
748
Las Vegas Sands
LVS
$27.4B
| – | – |
-656,712
| Closed | -$34.5M |
|
749
Manhattan Associates
MANH
$12.3B
| – | – |
-42,343
| Closed | -$2.53M |
|
750
MPLX
MPLX
$59.7B
| – | – |
-137,735
| Closed | -$9.83M |
|
Similar funds
Jennison Associates's Q3 2015 Portfolio in Review
As of Q3 2015, Jennison Associates held 813 positions worth $97.6B, down 11% from $109B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Jennison Associates's Q3 2015 filing shows 84 new, 272 increased, 353 reduced and 92 closed positions. Its largest new stake was Palo Alto Networks: 12,124,434 shares worth $348M. The largest sale was Gilead Sciences, an estimated $722M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Communication Services.
- Jennison Associates's largest Q3 2015 buy was Palo Alto Networks: 12,124,434 shares worth $348M.
- Jennison Associates added most to Alphabet (Google) Class C in Q3 2015, an estimated $820M increase.
- Jennison Associates's biggest Q3 2015 reduction was Gilead Sciences, cutting an estimated $722M.
- Jennison Associates fully exited KRAFT FOODS GROUP INC COM STK (VA) in Q3 2015, selling an estimated $144M.
- Jennison Associates's ten largest holdings make up 24% of its $97.6B portfolio in Q3 2015.
- Jennison Associates opened 84 new positions and closed 92 in Q3 2015.
- Jennison Associates's portfolio value fell 11% quarter-over-quarter to $97.6B.
Based on Jennison Associates's 13F filing for Q3 2015, filed 6 Nov 2015.